Srinivasan and another tech investor tied to PayPal cofounder and Trump transition team member Peter Thiel, Mithril Capital Management managing director of investment Jim O’Neill, both met with Trump Jan. 12.
The duo is being considered for a top FDA position, incoming White House press secretary Sean Spicer said, according to a CNBC report.
His expertise in health regulation stems back to a start-up he co-founded, Counsyl, which offers DNA screening, especially for people considering having children. CNBC reported.
The Indian American executive has been on record in the past criticizing the FDA, saying “big bad pharma does exist,” adding that the administration “sets the incentives.”
He was the chief technology officer and co-founder of Counsyl, a genomics startup that began in a Stanford dorm room and now tests four percent of all U.S. births, until 2012 when he stepped back from an executive role in November 2012 to work on other areas of technology.